Status: Completed
ClinicalTrials.gov Identifier: NCT00789477
VGFT-OD-0706: Phase 2 study of intravitreal injections of Aflibercept in patients with Diabetic Macular Edema.
Condition: Diabetic Macular Edema
Study Type: Interventional
Duration: 21 months
Eligibility:
For additional information on this study, please click here
Back to Clinical Research